TITLE

Clinical Management of Cutaneous Vasculitis in a Horse

AUTHOR(S)
Gupta, D. K.; Dhaliwal, P. S.; Chand, Naimi; Bansal, B. K.
PUB. DATE
January 2013
SOURCE
Intas Polivet;Jan-Jun2013, Vol. 14 Issue 1, p169
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
A bay coloured five years old male horse was presented with primary complaint of swelling on neck, right abdomen and hind limbs. The horse had problem in taking feed and water due to rigidity of neck muscles. Laboratory examination revealed neutrophilic leucocytosis, normocytic normochromic anaemia, absence of haemoprotozoa and elevated levels of alkaline phosphatase and creatinine kinase. The serum was negative for Trypanosomosis/ Equine Viral Arteritis/ Equine Granulomatous Enteritis/ Purpura Haemorrhagica (Streptococcal antigens). The case was then differentially diagnosed as Cutaneous Vasculitis. Antibiotics, corticosteriods, liver tonic and appetite stimulants were given for more than a week and kept indoor under observation.The swelling started receding from the face and neck and animal began to take feed adequately during the course of treatment. The animal was cured within eighteen days of treatment and discharged with the advisement of treatment.
ACCESSION #
90545159

 

Related Articles

  • Tocilizumab: a novel therapy for patients with large-vessel vasculitis. Salvarani, Carlo; Magnani, Luca; Catanoso, Mariagrazia; Pipitone, Nicolò; Versari, Annibale; Dardani, Lucia; Pulsatelli, Lia; Meliconi, Riccardo; Boiardi, Luigi // Rheumatology;Jan2012, Vol. 51 Issue 1, p151 

    Objective. Treatment of large-vessel vasculitis (LVV) remains challenging. Patients usually respond to glucocorticoid (GC) therapy, but often relapse on tapering of the GC dose or after GC withdrawal. In addition, GCs are fraught with numerous adverse events. The aim of this study was to assess...

  • Therapeutic Interventions for Systemic Vasculitis. Hoffman, Gary S. // JAMA: Journal of the American Medical Association;12/1/2010, Vol. 304 Issue 21, p2413 

    The author reflects on the therapeutic interventions that were developed for systemic vasculitis. He recalls that in the past, the literature on vascultis was primarily descriptive, in which reports were mostly from single centers and treatment outcomes were compared with historical controls. He...

  • From the editor's desk - Vasculitis my brief synopsis. Natarajan, S. // Indian Journal of Ophthalmology;Jul2011, Vol. 59 Issue 4, p271 

    The author reflects on the retinal vasculitis, an inflammation of the retinal vasculature. The author says that whenever Indians think of vasculitis, tuberculosis (TB) comes out their minds as the first diagnosis. The author suggests that if vasculitis does not react to corticosteroids, a...

  • Daily and Alternate-day Corticosteroid Regimens in Treatment of Giant Cell Arteritis. Hunder, Gene G.; Shelps, Sheldon G.; Allen, George L.; Joyce, John W. // Annals of Internal Medicine;May75, Vol. 82 Issue 5, p613 

    Presents a study which investigated the therapeutic effectiveness of alternate-day corticosteroid therapy in giant cell arteritis. Patients and method used in the study; Symptoms of giant cell arteritis; Results; Side effects related to prednisone; Discussion.

  • Etanercept in giant cell arteritis.  // Age & Ageing;Nov2008, Vol. 37 Issue 6, p616 

    The article discusses a study of patients with giant cell arteritis (GCA) on etanercept, a drug that suppresses tumor necrosis factor. Etanercept has been used as a potential alternative to corticosteroids in GCA. After 12 months, patients on etanercept had higher levels of glycemia. GCA was...

  • Visual loss when treating giant cell arteritis. Thomas, D. J. // Practical Neurology (BMJ Publishing Group);Dec2006, Vol. 6 Issue 6, p384 

    The article presents two medical cases which demonstrate the danger of sudden and permanent visual loss in patients being treated for giant cell arteritis. As a result of these two cases, the author now recommends anti-thrombotic treatment combined with steroid therapy in those patients who are...

  • Initiation of Glucocorticoid Therapy: Before or After Temporal Artery Biopsy? Younge, Brian R.; Cook Jr., Briggs E.; Bartley, George B.; Hodge, David O.; Hunder, Gene G. // Mayo Clinic Proceedings;Apr2004, Vol. 79 Issue 4, p483 

    • Objective: To identify clinical findings in patients with suspected giant cell arteritis (GCA) that may help clinicians decide when to initiate glucocorticoid therapy. • Patients and Methods: Medical diagnostic codes and surgical indexing were used to identify all patients who had...

  • AMOXICILLIN AND CLAVULANATE POTASSIUM RELATED LEUCOCYTOCLASTIC VASCULITIS. Lunge, Snehal Balvant; Sajjan, Vijaya V.; Pandit, Ashok M.; Manjunathswamy, B. S.; Patil, Shivakumar; Agrawal, Anshul // Our Dermatology Online / Nasza Dermatologia Online;Apr2014, Vol. 5 Issue 2, p148 

    Leukocytoclastic vasculitis (LCV) is a small-vessel vasculitis with a reported incidence rate of 30 cases per million persons per year. It usually presents as a palpable purpuric skin rash on legs, though any part of the body can be affected. LCV rash may have an associated burning sensation or...

  • Dealing with Pig Flow, Site Issues. Rodibaugh, Max // National Hog Farmer;9/15/2003, Vol. 48 Issue 9, p27 

    Examines the effectiveness of all-in, all-out pig flow and multi-site production as a solution to swine health problems. Treatment of individual pigs with high doses of antibiotics and corticosteroids and water medication using sulfadimethoxine; Need to understand the patterns of disease...

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics